1. Improving outcomes in breast cancer: manual update;National Institute for Health and Clinical Excellence,2002
2. Optimal schedule of paclitaxel: weekly is better;Gonzalez-Angulo;J Clin Oncol,2008
3. Anglo-Celtic IV: first results of a UK National Cancer Research Network randomised phase 3 pharmacogenetic trial of weekly versus 3 weekly Paclitaxel in patients with locally advanced or metastatic breast cancer (ABC);Verrill;J Clin Oncol,2007
4. Improving Outcomes Guidance. Improving outcomes in breast cancer. NICE; August 2002. http://www.nice.org.uk/csgbc.